Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

Antiandrogen therapy helps treat genetic hair loss.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Minoxidil may help treat hair loss by reducing the activity of a specific enzyme linked to baldness.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

Antiandrogen treatment helps reduce hair follicles and sebaceous glands in hirsute women.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Antiandrogens like spironolactone can help treat female-pattern hair loss.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

In 2017, a new method was created to efficiently produce a topical antiandrogen, a compound used to treat excess sebum and acne, with a high yield and purity.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Clofazimine may be effective for treating ashy dermatosis.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Hidradenitis suppurativa improves with antiandrogen therapy.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Antiandrogen treatments can help with various women's health issues but often require ongoing use.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Antiandrogen therapy may help treat hidradenitis suppurativa.